Feng, Siwei http://orcid.org/0000-0001-6635-8978
McNehlan, Michael E. http://orcid.org/0000-0003-2038-1288
Kinsella, Rachel L.
Sur Chowdhury, Chanchal
Chavez, Sthefany M.
Naik, Sumanta K.
McKee, Samuel R. http://orcid.org/0009-0005-7166-2153
Van Winkle, Jacob A.
Dubey, Neha
Samuels, Amanda
Swain, Amanda
Cui, Xiaoyan
Hendrix, Skyler V.
Woodson, Reilly
Kreamalmeyer, Darren
Smirnov, Asya http://orcid.org/0000-0003-4767-1680
Artyomov, Maxim N. http://orcid.org/0000-0002-1133-4212
Virgin, Herbert W.
Wang, Ya-Ting http://orcid.org/0000-0002-5057-4083
Stallings, Christina L. http://orcid.org/0000-0002-2747-5618
Funding for this research was provided by:
Tsinghua University (Dushi 52302102523, School of Medicine 100001051)
Tsinghua-Peking Joint Center for Life Science
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI132697, U19 AI142784)
Burroughs Wellcome Fund (Investigators in the Pathogenesis of Infectious Disease)
Article History
Received: 12 June 2022
Accepted: 16 January 2024
First Online: 27 February 2024
Competing interests
: H.W.V. is a founder of Casma Therapeutics and the Vaccine Company. The work reported here was not funded by either company. H.W.V. also holds shares in Vir Biotechnology, which did not fund this work. All other authors declare no competing interests.